Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAPK7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OBP2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FXYD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFRSF9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMK2G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXC12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SV2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSSK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIA-RAB4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRIN3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR161 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STK11IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUS3L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPRIPL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BDKRB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on